Qiwen Yu

628 total citations
32 papers, 488 citations indexed

About

Qiwen Yu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Qiwen Yu has authored 32 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Qiwen Yu's work include Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (3 papers). Qiwen Yu is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (3 papers). Qiwen Yu collaborates with scholars based in China, Netherlands and Canada. Qiwen Yu's co-authors include Beili Xi, Yuebo Zhang, Ying Zang, Jingwu Z. Zhang, Hongguang Sheng, Xiaoyan Sheng, Lili Wu, Xia Qin, Guoliang Cui and Shuijun Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Qiwen Yu

28 papers receiving 477 citations

Peers

Countries citing papers authored by Qiwen Yu

Since Specialization

Citations

This map shows the geographic impact of Qiwen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiwen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiwen Yu more than expected).

Fields of papers citing papers by Qiwen Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiwen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiwen Yu. The network helps show where Qiwen Yu may publish in the future.

Co-authorship network of co-authors of Qiwen Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiwen Yu. A scholar is included among the top collaborators of Qiwen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiwen Yu. Qiwen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chronic stress promotes pancreatic ductal adenocarcinoma progression via complement C5a-recruited myeloid-derived suppressor cells 2025 ·Cancer Immunology Immunotherapy ·Siyuan Yang, Jianguo Li, (unknown), (unknown), Zhuomin Chen, Ran Wei, Rui He, Qiwen Yu, Zhengjian Yan, (unknown), Mengmeng Wang, (unknown), Jinping Hu, Lv Zhou, Zhen Feng, Huan Deng	0
2	Nanotuner targeting mitochondrial redox and iron homeostasis imbalance for the treatment of acute liver injury 2025 ·Theranostics ·Minghao Li, (unknown), Jie Gao, Xudong Liu, Jihua Shi, Wenzhi Guo, Yi Zhang, Qiwen Yu, Xinzhi Sun, Shuijun Zhang	0
3	Chronic stress synergizes with Listeria monocytogenes to promote intestinal adenomagenesis via myeloid-derived suppressor cells 2025 ·Frontiers in Immunology ·(unknown), Lili Yin, Ran Wei, Siyuan Yang, (unknown), Ping Huang, Qiwen Yu, (unknown), Mengmeng Wang, (unknown), Jinping Hu, Lv Zhou, Rui He, (unknown), Ying Xiong	0
4	Dysbiosis promotes recurrence of adenomatous polyps in the distal colorectum 2024 ·World Journal of Gastrointestinal Oncology ·Lili Yin, (unknown), Yunfei Hu, Xiaojun Fu, (unknown), Mengmeng Wang, (unknown), (unknown), Qiwen Yu, Jinping Hu, Lv Zhou, Zhibin Zhou, Ying Xiong, (unknown)	2
5	Sensors for surveillance of RNA viruses: a One Health perspective 2024 ·The Lancet Microbe ·Ye Chen, Peng Wang, Fenni Zhang, Hui Dai, (unknown), Xinyu Wang, Qiwen Yu, (unknown), Shuo Su, Di Wang	1
6	6-Gingerol attenuates hepatic ischemia/reperfusion injury through regulating MKP5-mediated P38/JNK pathway 2024 ·Scientific Reports ·Qiwen Yu, Jiye Li, (unknown), (unknown), (unknown), (unknown)	4
7	Piezocatalytic enhanced peroxymonosulfate activation for bisphenol F degradation with amorphous MoSx/h-BN: The pivotal role of sulfur vacancies 2023 ·Separation and Purification Technology ·(unknown), (unknown), Leliang Wu, Qiwen Yu, Wendi Zhou, Qiuyi Ji, Qiang Zhong, Yazi Liu, Gancheng Zuo, Zhe Xu, Shaogui Yang, Limin Zhang, Huan He	15
8	KLF6 alleviates hepatic ischemia-reperfusion injury by inhibiting autophagy 2023 ·Cell Death and Disease ·(unknown), Dongsheng Yu, (unknown), Qiwen Yu, (unknown), (unknown), Shuijun Zhang	23
9	Mitogen activated protein kinase phosphatase 5 alleviates liver ischemia–reperfusion injury by inhibiting TAK1/JNK/p38 pathway 2023 ·Scientific Reports ·Qiwen Yu, Sanyang Chen, Jiye Li, Hongwei Tang, Jihua Shi, Wenzhi Guo, Shuijun Zhang	6
10	Adelmidrol ameliorates liver ischemia-reperfusion injury through activating Nrf2 signaling pathway 2023 ·European Journal of Pharmacology ·(unknown), Xudong Liu, Qiwen Yu, Jihua Shi, Wenzhi Guo, Shuijun Zhang	4
11	Inhibition of macrophage migration inhibitory factor (MIF) suppresses apoptosis signal-regulating kinase 1 to protect against liver ischemia/reperfusion injury 2022 ·Frontiers in Pharmacology ·Sanyang Chen, Qiwen Yu, (unknown), (unknown), Mengke Li, (unknown), (unknown), Shengli Cao, Changju Zhu	8
12	Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma 2022 ·Frontiers in Pharmacology ·Chi Liu, Jie Gao, Dongjing Yang, Qiwen Yu, Shuijun Zhang	1
13	Veratric acid alleviates liver ischemia/reperfusion injury by activating the Nrf2 signaling pathway 2021 ·International Immunopharmacology ·Qiwen Yu, Sanyang Chen, Hongwei Tang, Xiaodan Zhang, (unknown), (unknown), Jihua Shi, Wenzhi Guo, Shuijun Zhang	18
14	Hyperprogression under immunotherapy: a new form of immunotherapy response?—a narrative literature review 2021 ·Translational Lung Cancer Research ·(unknown), Ben Vanneste, Qiwen Yu, Zebin Chen, Jiayu Peng, Xiuyu Cai	18
15	Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritis 2011 ·Cellular and Molecular Immunology ·(unknown), Qian Liu, Yi Miao, (unknown), Ping Miao, Ping Wang, Qiwen Yu, Hong Nie, Jiying Zhang, Dongyi He, (unknown), Xuehua Chen, Bingya Liu, Dongqing Zhang	44
16	Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation 2011 ·Journal of Clinical Investigation ·Guoliang Cui, Xia Qin, Lili Wu, Yuebo Zhang, Xiaoyan Sheng, Qiwen Yu, Hongguang Sheng, Beili Xi, Jingwu Z. Zhang, Ying Zang	225
17	Active chinese mistletoe lectin-55 enhances colon cancer surveillance through regulating innate and adaptive immune responses 2008 ·World Journal of Gastroenterology ·Yanhui Ma, (unknown), Fang Gong, Anlun Ma, Qiwen Yu, Jiying Zhang, (unknown), Xuehua Chen, Dongqing Zhang	25
18	A Lectin from Chinese Mistletoe Increases γδ T Cell-mediated Cytotoxicity through Induction of Caspase-dependent Apoptosis 2007 ·Acta Biochimica et Biophysica Sinica ·Fang Gong, Yanhui Ma, Anlun Ma, Qiwen Yu, Jiying Zhang, Hong Nie, Xuehua Chen, Baihua Shen, Ningli Li, Dongqing Zhang	14
19	Preliminary study on establishing the experimental immunosuppression model of allogynogenetic silver crucian carp 2004 ·JOURNAL OF FISHERIES OF CHINA ·Yong Chen, (unknown), Qiwen Yu, Jiying Zhang, Baihua Shen, (unknown)	2
20	The immuno-suppressive effects of cyclophosphamide and Aeromonas Hydrophila on Fugu Obscurus 2004 ·Xueming Hua, (unknown), Qiwen Yu, Baihua Shen, Jiying Zhang, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact